United Kingdom, June 1, 2017: Welcome to the second edition of the European Medical Journal of 2017, packed full of high-quality, peer-reviewed articles covering a wide range of therapeutic areas. Featured in this edition are some fascinating papers on the topics of medical innovation, neurology, cardiology, and urology, all aiming to provide food for thought for healthcare professionals across the board.
The feature for this edition comes courtesy of Antoniou and Yassin, who contemplate the topic of vaginal rejuvenation, an increasingly popular cosmetic surgery but one without firmly established data on safety and efficacy due to low patient numbers and short follow-ups in pilot studies. In addition, the authors attempt to answer what might influence women who are undertaking these procedures and the need for increased regulation of devices used.
Alongside this, there is a range of medical innovations papers, which are sure to capture the imagination. Lauridsen reviews the potential of regenerative biology and medicine in restoring tissue lost to damage or disease, something which, he explains, leads to many diseases in humans because of our inability to regenerate tissue. Additionally, Osae-Larbi considers digital healthcare solutions for chronic illnesses in the context increased numbers of migrants and refugees across the world. She argues that, in order to meet the needs of these populations, mobile digital healthcare solutions must be smart and innovative and there must be well-thought-out strategies for utilising this technology in the most efficient way possible. Virtual reality and the sight of one’s own body is the subject of Zanini et al.’s paper: ‘Pain During Illusory Own Arm Movement: A Study in Immersive Virtual Reality’, in which the authors discuss the implications of their study into the analgesic effect of the vision of own arm movement. Dias et al. also discuss the GLOBE programme in the context of patient-desired outcomes in treatments.
From the therapeutic area of cardiology, Feeman Jnr discusses his concerns on the use of non-high-density lipoprotein cholesterol as a lipid predictor and offers his suggestions for more accurate methods; from neurology, Rygiel discusses chronic pain syndrome in the context of diabetic neuropathy and postherpetic neuralgia; and from urology, do Amaral reviews a treatment option for docetaxel-resistant prostate cancer. All available online: http://viewer.zmags.com/publication/39024323#/39024323/1
The European Medical Journal hopes that this latest edition will inspire debate and discussion, as well as helping to inform the practice of healthcare professionals. Zoë Webster, Publisher at EMJ, commented: “European Medical Journal 2.2 is the latest in our quarterly editions of the journal, and one that we are immensely proud of. We hope that our subscribers will enjoy reading the papers included as much as we did.”
About the European Medical Journal
The European Medical Journal is an independent company that annually produces a collection of open-access medical eJournals covering therapeutic areas such as Respiratory, Gastroenterology, Cardiology, and Urology. By combining editorials from key opinion leaders with concise news coverage from the leading congresses within the medical industry, we aim to deliver first-class insight into ground-breaking changes and advances in medicine. The production of our high-quality, peer-reviewed eJournals, and our collaborations with independent clinical bodies result in a dynamic and contemporary tool with which to assist industry professionals across Europe in progressively developing their performance and efficacy.
Name: Stacey Rivers
Number: 01245 334452
E-mail: [email protected]